[Possible uses of nootrophic drugs in clinical psychiatry (author's transl)]. 1978

J Molcan, and O Vinar, and R Pribyl, and E Kolibás, and T Caplová, and A Heretík

UI MeSH Term Description Entries
D008297 Male Males
D008606 Mental Processes Conceptual functions or thinking in all its forms. Information Processing, Human,Human Information Processing
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010889 Piracetam A compound suggested to be both a nootropic and a neuroprotective agent. 2-Pyrrolidone-N-Acetamide,Avigilen,Axonyl,Cerebroforte,Cerepar N,Ciclofalina,Cuxabrain,Dinagen,Gabacet,Geram,Memo-Puren,Nootrop,Nootropil,Nootropyl,Normabraïn,Piracebral,Piracetam AbZ,Piracetam-RPh,Piracetrop,Pirazetam,Pyracetam,Pyramem,Sinapsan,UCB-6215,Memo Puren,Piracetam RPh,UCB 6215,UCB6215
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D011760 Pyrrolidinones A group of compounds that are derivatives of oxo-pyrrolidines. A member of this group is 2-oxo pyrrolidine, which is an intermediate in the manufacture of polyvinylpyrrolidone. (From Merck Index, 11th ed) Pyrrolidinone,Pyrrolidone,Pyrrolidones
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003072 Cognition Disorders Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment. Overinclusion,Disorder, Cognition,Disorders, Cognition
D003244 Consciousness Disorders Organic mental disorders in which there is impairment of the ability to maintain awareness of self and environment and to respond to environmental stimuli. Dysfunction of the cerebral hemispheres or brain stem RETICULAR FORMATION may result in this condition. Consciousness, Level Altered,Disorder of Consciousness,Disorders of Consciousness,Semiconsciousness,Altered Level of Consciousness,Consciousness, Level Depressed,Depressed Level of Consciousness,Consciousness Disorder
D005260 Female Females

Related Publications

J Molcan, and O Vinar, and R Pribyl, and E Kolibás, and T Caplová, and A Heretík
November 1977, Psychiatrische Praxis,
J Molcan, and O Vinar, and R Pribyl, and E Kolibás, and T Caplová, and A Heretík
April 1978, Ceskoslovenska psychiatrie,
J Molcan, and O Vinar, and R Pribyl, and E Kolibás, and T Caplová, and A Heretík
March 1974, Laryngologie, Rhinologie, Otologie,
J Molcan, and O Vinar, and R Pribyl, and E Kolibás, and T Caplová, and A Heretík
July 1974, Ceskoslovenska psychiatrie,
J Molcan, and O Vinar, and R Pribyl, and E Kolibás, and T Caplová, and A Heretík
November 1980, Casopis lekaru ceskych,
J Molcan, and O Vinar, and R Pribyl, and E Kolibás, and T Caplová, and A Heretík
August 1975, Das Offentliche Gesundheitswesen,
J Molcan, and O Vinar, and R Pribyl, and E Kolibás, and T Caplová, and A Heretík
December 1975, Ceskoslovenska psychiatrie,
J Molcan, and O Vinar, and R Pribyl, and E Kolibás, and T Caplová, and A Heretík
February 1979, Ceskoslovenska psychiatrie,
J Molcan, and O Vinar, and R Pribyl, and E Kolibás, and T Caplová, and A Heretík
February 1979, Praktische Anasthesie, Wiederbelebung und Intensivtherapie,
J Molcan, and O Vinar, and R Pribyl, and E Kolibás, and T Caplová, and A Heretík
December 1978, Journal of the South African Veterinary Association,
Copied contents to your clipboard!